Table 1.
Study and case reports of triple sleeve lobectomies
Solli et al,1 2001 | Sekine et al,2 2006 | Pochesci et al,3 2008 | Sun et al,4 2013 |
Zhu et al,5 2015 | Present report | ||||
---|---|---|---|---|---|---|---|---|---|
Case 1 | Case 2 | Case 3 | Case 4 | ||||||
SVC plasty/SVC graft | Graft | Graft | Graft | Graft | Graft | ||||
Pathology | ADK | SCC | SCC | Large cell carcinoma | ADK | ADK | SCC | SCC | Pleomorphic carcinoma |
Pathological stage | pT4N1M0R0 | pT4N2M0R0 | NR | pT4N2M0R0 | pT4N2M0R0 | pT4N1M0R0 | pT2aN2M0R0 | NR | pT4N2M0R0 |
Adjuvant therapy | 0 | NR | NR | Cisplatin + gemcitabine | Cisplatin + gemcitabine | Cisplatin + gemcitabine + radiotherapy | Cisplatin + gemcitabine + radiotherapy | Cisplatin + gemcitabine + radiotherapy | 1 regimen cisplatin + Navelbine |
Reported survival | Alive at 13 mo | More than 3 y | Alive at 1 y | Alive at 32 mo | Died at 21 mo | Alive at 38 mo | Died at 22 mo | Died at 21 mo | Died at 54 mo |
SVC, Superior vena cava; ADK, adenocarcinoma; SCC, squamous cell carcinoma; NR, not reported.